Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Fetal Therapy for Congenital Pulmonary Malformations: A Prospective Population‐Based National Cohort Study

Title: Fetal Therapy for Congenital Pulmonary Malformations: A Prospective Population‐Based National Cohort Study
Authors: Weber, Mathilde; Monier, Isabelle; Rahshenas, Makan; Salomon, Laurent J.; Sananes, Nicolas; Castaigne, Vanina; Houfflin‐Debarge, Véronique; Jouannic, Jean‐Marie; Massardier, Jérôme; Tsatsaris, Vassilis; Khoshnood, Babak; Lelong, Nathalie; Delacourt, Christophe; Benachi, Alexandra
Source: Prenatal Diagnosis ; volume 44, issue 12, page 1536-1547 ; ISSN 0197-3851 1097-0223
Publisher Information: Wiley
Publication Year: 2024
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Objective To assess the frequency of fetal therapy for fetuses with congenital pulmonary malformations (CPMs) and to investigate their short‐term outcomes. Method The study population included 435 singleton fetuses diagnosed with CPMs from a national population‐based cohort study in France in 2015–2018. Information was obtained from medical records on CPM volume ratio (CVR), signs of compression, fetal therapy and perinatal outcomes. The characteristics and outcomes of fetuses with and without fetal therapy were compared using a univariate test. Results Twenty six fetuses (6.0%, 95% CI: 4.1–8.6) received at least one fetal therapy including thoracoamniotic shunts only ( n = 3), antenatal steroids only ( n = 12), and a combination of several therapies including thoracentesis and amniodrainage, in addition to shunts and steroids ( n = 11). Compared with fetuses without fetal therapy, those who did have higher CVR (1.6 ± 0.3 vs. 0.7 ± 0.04, p < 0.001) and more severe signs of compression (73.1% vs. 12.8%, p < 0.001). The proportion of live births after fetal therapy was 84.6% versus 98.5% ( p < 0.001) for those without fetal therapy and the hospital mortality rate was 13.6% versus 1.0% ( p = 0.004), respectively. Conclusion A small minority of fetuses with CPMs underwent fetal therapy. These patients had a lower survival compared with those who did not receive fetal therapy. Trial Registration NCT02352207
Document Type: article in journal/newspaper
Language: English
DOI: 10.1002/pd.6646
Availability: https://doi.org/10.1002/pd.6646; https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/pd.6646
Rights: http://creativecommons.org/licenses/by-nc/4.0/
Accession Number: edsbas.200F4BF7
Database: BASE